GlassScriptPhysician profile
Alissa Morrone
NPI 1851810972
$21,407.94
in general payments reported to CMS, 2019-2025
27 companies · $9,971 in 2025
The $9,971 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,995 · 2022: $2,129 · 2023: $2,976 · 2024: $4,336 · 2025: $9,971.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,987 · Consulting Fee: $5,208 · Honoraria: $1,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $600 · Education: $254 · Travel and Lodging: $235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,986.62 |
| Consulting Fee | $5,208.00 |
| Honoraria | $1,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $600.00 |
| Education | $253.94 |
| Travel and Lodging | $235.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eli Lilly and Company | $3,500.40 | 2025 | Ebglyss |
| Sun Pharmaceutical Industries INC. | $2,207.97 | 2021-2025 | Winlevi, Absorica Ld, Ilumya |
| Abbvie INC. | $1,878.31 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,791.28 | 2021-2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $1,431.86 | 2021-2025 | Nemluvio, Aklief, Twyneo |
| Janssen Biotech, INC. | $1,379.07 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Leo Pharma INC. | $1,133.94 | 2021-2025 | Adbry, Anzupgo |
| Genzyme Corporation | $1,084.27 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $1,061.33 | 2022-2024 | |
| Lilly USA, LLC | $990.49 | 2021-2025 | Ebglyss, Taltz, Olumiant |
| Novartis Pharmaceuticals Corporation | $753.17 | 2021-2025 | |
| Incyte Corporation | $747.82 | 2021-2025 | Opzelura, Opzelura |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $567.80 | 2021-2025 | Jublia, Cabtreo, Arazlo |
| E.R. Squibb & Sons, L.L.C. | $566.76 | 2022-2025 | Sotyktu |
| Ucb, INC. | $553.65 | 2021-2025 | Bimzelx, Cimzia |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $466.14 | 2021-2025 | Otezla, Otezla |
| Journey Medical Corporation | $318.29 | 2022-2025 | |
| Almirall LLC | $245.31 | 2021-2023 | Klisyri |
| Pfizer INC. | $184.79 | 2021-2023 | |
| Arcutis Biotherapeutics, INC. | $184.50 | 2023-2025 | Zoryve |
| Organon LLC | $108.87 | 2025 | Vtama |
| Janssen Scientific Affairs, LLC | $92.00 | 2024 | Tremfya |
| Dermavant Sciences, INC. | $78.81 | 2023-2024 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.32 | 2023 | Cyltezo |
| Vyne Pharmaceuticals INC. | $23.14 | 2021 | |
| Botanix Sb INC | $21.86 | 2025 | Sofdra |
| Epi Health, LLC | $12.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alissa Morrone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.